Displaying All Posts : May 2012

Lung Cancer Is Not Just For Smokers

10.31.11 Dave Fisher

While the majority of people with lung cancer are lifetime smokers, 15 percent are actually diagnosed having never smoked. Read More

Weekly Imaging News Roundup

10.28.11 Dave Fisher

This week’s must read: House introduces bill to stop imaging cuts, new mammogram technology is revolutionizing breast cancer detection, breast MRI improves diagnosis and efficiency, CT scans help detect COPD and a new study casts doubt on prior authorization. Read More

House Introduces Imaging Bill

10.28.11 Dave Fisher

HR 3269, the Diagnostic Imaging Services Protection Act of 2011 was introduced yesterday to prevent imaging cuts to Medicare. Read More

Low-Dose CT Detects COPD

10.26.11 Dave Fisher

In a study published in the Journal of the American Medical Association (JAMA) on Tuesday, researchers in Europe found that low-dose CT may also “help physicians detect chronic obstructive pulmonary disease, known as COPD, in smokers.” Read More

Scan Results, There’s An App For That

10.24.11 Dave Fisher

More and more doctors use tablets and smartphones to help treat their patients. The FDA has already cleared several diagnostic imaging apps for use, and more are likely as prevalence for these devices in clinical settings continues to rise. Read More

Weekly Imaging News Roundup

10.23.11 Dave Fisher

This week’s must read: House of Representatives offers bills to revise FDA device rules and protect innovation, Senator Scott Brown (D-MA) takes aim at medical device tax, male breast cancer rare, but aggressive and new imaging apps. Read More

Celebrity Finds Breast Cancer Early, Saves Life

10.17.11 Dave Fisher

This morning on TODAY, E! Network’s celebrity news personality Giuliana Rancic announced that she has breast cancer. Read More

Weekly Imaging News Roundup

10.14.11 Dave Fisher

This week’s must read: legislation aims to spur innovation, think tank critical of FDA regulatory policy, iPhone app bridging access gap in devleoping countries, PET agent visualizes tumors at earliest stages and FDA and Medicare launch “parallel review” process. Read More

New Report Critical of FDA Review Process

10.13.11 Dave Fisher

A recent report from the Competitive Enterprise Institute found the FDA is overly burdensome for manufacturers when it comes to the Agency’s review of medical devices. Read More

Recent Posts

RSS

Stay Informed

Stay Informed

Sign up for news and information from MITA.